TMDX MEXC RealStocks
Own real TMDX shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 06:15:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
TransMedics Group, Inc. (TMDX) operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $96.42, with a market capitalization of $3.26B and a P/E ratio of 22.58. Over the past 52 weeks, its price has ranged from $60.11 to $156.00. This page covers its latest market performance, valuation, price trends and company information.
$3.26B | |
$93.89 | |
$98.70 | |
$92.62 | |
$93.91 | |
934.29K | |
914.29K | |
22.58 | |
$156.00 | |
$60.11 | |
-- | |
2026-09-30 |
TransMedics Group, Inc. (TMDX) last closed at $96.42 as of 2026-11-19 00:39:00, up 2.75% ($2.59) from the previous close of $93.91.
During the latest regular trading session, TMDX traded between $92.62 and $98.70, with a volume of 934.29K shares. The closing price was near the middle and near the middle of its 52-week range.
Over the past seven days, TransMedics Group, Inc. (TMDX) moved from $90.95 to $96.42, representing a gain of 6.02% ($5.48).
The stock traded between $89.48 and $98.78 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 1.01 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 37.9%
TMDX is currently trading at $96.42, placing it 37.9% of the way from its 52-week low of $60.11 to its 52-week high of $156.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
| Industry | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Employees | 898 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of TransMedics Group, Inc. (TMDX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to TMDX, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between TMDX shares and USD.
TMDX Shares to USD
1.00 TMDX shares = 96.421 USD
Calculations are estimates based on the latest available price and are for reference only.